Future studies comparing and contrasting the number and location of conserved and strain-specific MSP1 epitopes targeted by IgG and IgM antibodies before and after SUM-101 vaccination in malaria naïve and malaria pre-exposed populations will allow to dissect the proportion of recall versus de novo generated antibody specificities. This evidence concerns the gene CD40LG and malaria.